Update on the management of emphysematous pyelonephritis
Emphysematous pyelonephritis is a severe necrotizing infection of the upper urinary tract in which gas develops in the renal parenchyma or collecting system. It is most often associated with diabetes mellitus and urinary obstruction, while gas-forming organisms such as Escherichia coli and Klebsiella species are common. The illness can progress from pyelonephritis to abscess formation, perinephric extension, septic shock and kidney failure within hours to days, making emergency assessment essential.
Contemporary care combines sepsis resuscitation, broad-spectrum antibiotics and timely source control. The balance depends on imaging, physiological stability and the extent of infection rather than the presence of gas alone. Peer-reviewed reviews and society guidance, including material in the Urological Science journal, support a coordinated emergency pathway involving urology, infectious diseases, radiology and critical care.
Recognising infection and stratifying risk
Diagnosis should combine systemic illness with renal imaging. Contrast-enhanced CT of the abdomen and pelvis is preferred when the patient is stable enough for transport, because it maps intrarenal gas, abscesses, stones, obstruction and perinephric extension. Ultrasound may reveal echogenic gas or hydronephrosis but can miss the full extent of disease. Blood cultures, urine culture, full blood count, electrolytes, renal function, lactate and coagulation results support risk assessment; urine cultures may be negative because gas-forming organisms are difficult to culture.
| Management approach | Best-supported use | Main requirements | Important limitation |
|---|---|---|---|
| Antibiotics with inpatient monitoring | Selected stable patients without obstruction, drainable abscess or extrarenal extension | Broad-spectrum intravenous therapy, cultures and close clinical and imaging review | Deterioration can be rapid, and observation requires a low threshold for drainage |
| Urinary drainage | Obstruction, infected collecting system or persistent sepsis | Ureteric stent or nephrostomy alongside antibiotics | Drainage of the collecting system does not always evacuate parenchymal or perinephric pus |
| Percutaneous abscess drainage | A drainable collection alongside antimicrobial treatment | Image-guided catheter placement, culture of drained material and repeat review | Access can be difficult, and repeated procedures may be required |
| Operative source control | Extensive tissue destruction, failed drainage or uncontrolled sepsis | Nephrectomy or operative clearance of infected material by an experienced team | It carries greater morbidity and a longer recovery than less invasive approaches |
The Huang–Tseng classification helps describe severity: class 1 involves gas confined to the collecting system, sometimes termed emphysematous pyelitis; class 2 gas in the renal parenchyma without extension; class 3A and 3B extension into perinephric and pararenal spaces; and class 4 bilateral disease or disease in a solitary kidney. These categories support communication, but they are not a substitute for clinical judgement. A stable patient with limited disease may be managed conservatively, whereas shock or extensive gas can require urgent intervention even without a stone. Readers who want an example of how the journal presents clinical evidence can consult its sample clinical article.
Resuscitation and antimicrobial treatment
Suspected emphysematous pyelonephritis should be managed as sepsis. Give oxygen, establish intravenous access, measure lactate and begin fluid resuscitation while monitoring blood pressure, urine output, glucose and signs of organ dysfunction. Septic shock requires critical care support and vasopressors, usually noradrenaline, alongside antibiotics and source control. Obtain blood and urine cultures before treatment when this causes no meaningful delay.
Antibiotic selection should reflect likely pathogens, previous cultures, healthcare exposure, local antibiograms, allergies and kidney function. Ceftriaxone may be suitable for many community-acquired susceptible infections, while piperacillin–tazobactam is commonly used for severe or healthcare-associated infection; a carbapenem may be appropriate when resistance risk is high. Dose adjustment and close review are essential in acute kidney injury. Metronidazole is not routinely required for gas caused by E. coli or Klebsiella, but anaerobic cover may be added when a mixed infection is suspected.
Antibiotics should not be stopped merely because imaging improves. Duration is guided by cultures, blood-pressure recovery, inflammatory markers and whether adequate source control was achieved; many regimens extend for several weeks, with IV-to-oral transition once the patient is stable and able to take oral medicines. Failure to improve should prompt renewed imaging and reconsideration of drainage, not simply a broader antibiotic choice.
Defining the need for source control
Source control means eliminating infected material and restoring urinary drainage. It is as important as antibiotics in complicated EPN and should be planned as soon as instability, obstruction, an abscess or extrarenal extension is identified. Delaying decompression in an infected obstructed system increases the risk of persistent bacteraemia and septic shock. A multidisciplinary response is more reliable than sequential, delayed referrals.
Antibiotics alone are reserved for carefully selected, stable patients with limited disease, adequate renal function, no drainable collection and close inpatient review. This is not appropriate for obstruction with infected urine, perinephric or pararenal pus, persistent hypotension, profound neutrophilia or worsening kidney function. The need for intervention also rises when gas involves renal parenchyma rather than remaining confined to the collecting system. A wider evidence-education resource, including practical clinical resources, can help teams align escalation thresholds with source-control principles.
Urgent drainage decision points
Drainage may mean bypassing the obstruction, evacuating a collection or removing nonviable infected tissue. The route depends on anatomy, sepsis severity and local expertise. Nephrostomy often provides direct drainage and a specimen for culture, while retrograde ureteric stenting can be effective in selected stable patients when upper-tract access is straightforward.
Urgent decompression is strongly indicated when:
- An obstructed, infected upper urinary tract with pyonephrosis cannot drain
- Septic shock or rapidly worsening hypotension is present
- Urinary diversion is obstructed or blocked
- Worsening kidney function suggests unrelieved obstruction
Operative source control becomes more likely when:
- Renal destruction is extensive or the kidney is nonfunctioning
- Collections persist despite antibiotics and percutaneous drainage
- Bacteraemia, fever or vasopressor dependence continues despite adequate drainage
- An infected obstructing stone or necrotic tissue prevents clearance
A percutaneous nephrostomy is frequently favoured in severe infection because it decompresses the collecting system and can drain adjacent material. Retrograde access is reasonable when the anatomy permits and should not delay definitive drainage in an unstable patient. Repeat imaging is needed when clinical improvement is uncertain, and a residual collection should not be dismissed because the patient feels better.
Australian pathways and ongoing care
Major public and private hospitals in Sydney, Melbourne, Brisbane, Perth and Adelaide generally provide around-the-clock emergency medicine, CT, critical care, urology and interventional radiology, although referral pathways differ. A patient with suspected EPN needs emergency assessment rather than a routine GP appointment; 000 is the Australian emergency number, and regional services should use local retrieval and transfer protocols.
The local medicine market and regulation strongly influence treatment. The Therapeutic Goods Act 1985 governs market authorisation through the TGA, and approved product information must guide prescribing. Ceftriaxone, piperacillin–tazobactam and carbapenems are available through Australian hospital formularies, with selection governed by local antibiograms and stewardship. The Commonwealth’s Pharmaceutical Benefits Scheme subsidises many outpatient medicines, whereas inpatient antibiotics are generally supplied under hospital funding arrangements. Australian Commission on Safety and Quality in Health Care standards require antimicrobial stewardship, infection prevention and medication safety, so de-escalation and documentation are active responsibilities.
Environmental and social factors also affect recurrence and access. Hot weather, dehydration and a history of recurrent urinary stones can complicate recovery, while diabetes requires intensified glucose management. In northern and remote Australia, travel for imaging or drainage may be necessary; Aboriginal Medical Services and Aboriginal Community Controlled Health Organisations can support culturally safe follow-up for communities with a higher burden of diabetes and kidney disease. Editorial and professional collaboration is equally relevant, and the Taiwan Urological Association provides international context for the urology community publishing this journal.
Acting when every hour matters
After recovery, review the original infected kidney with renal function testing and appropriate imaging, and arrange urology follow-up for obstruction, stones, structural abnormalities or a poorly functioning kidney. Diabetes, glycaemic control, recurrent urinary tract infection and dehydration should be addressed. Antibiotic stewardship does not mean undertreating infection; it means obtaining cultures, narrowing therapy promptly and avoiding unnecessary continuation once infection is controlled.
Patients and families should receive clear advice about fever, rigors, flank pain, vomiting, reduced urine output or worsening confusion. Those with diabetes, recurrent stones, prior urinary obstruction or recurrent pyelonephritis warrant earlier medical review. Local health services should maintain a clear pathway for blood cultures, CT imaging, broad-spectrum antibiotics, urology and interventional radiology.
Treat every suspected case as time-critical: stabilise the patient, obtain cultures without delaying therapy, start broad-spectrum antibiotics, obtain contrast CT when safe, and activate urology, interventional radiology and critical care for prompt decompression and source control.